Opinion statement
Dyssomnias are sleep disorders associated with complaints of insomnia or hypersomnia. The daytime sleepiness of narcolepsy is treated by a combination of planned daytime naps, regular exercise medications such as modafinil, or salts of methylphenidate, or amphetamine. Cataplexy that accompanies narcolepsy is treated with anticholinergic agents, selective serotonin reuptake inhibitors, or sodium oxybate. Children with neurodevelopmental disabilities such as autism have sleep initiation and maintenance difficulties on a multifactorial basis, with favorable response to melatonin in some patients. Childhood onset restless legs syndrome is often familial, associated with systemic iron deficiency, and responsive to iron supplementation and gabapentin. Parasomnias are episodic phenomena events which occur at the sleep -- wake transition or by intrusion on to sleep. Arousal parasomnias such as confusional arousals and sleep walking can sometimes be confused with seizures. A scheme for differentiating arousal parasomnias from nocturnal seizures is provided. Since arousal parasomnias are often triggered by sleep apnea, restless legs syndrome, or acid reflux, treatment measures directed specifically at these disorders often helps in resolution. Clonazepam provided in a low dose at bedtime can also alleviate sleep walking and confusional arousals. Obstructive sleep apnea affects about 2 percent of children. Adeno-tonsillar hypertrophy, cranio-facial anomalies, and obesity are common predisposing factors. Mild obstructive sleep apnea can be treated using a combination of nasal corticosteroids and a leukotriene antagonist. Moderate to severe obstructive sleep apnea are treated with adeno-tonsillectomy, positive airway pressure breathing devices, or weight reduction as indicated. This paper provides an overview of the topic, with an emphasis on management steps. Where possible, the level of evidence for treatment recommendations is indicated.
Similar content being viewed by others
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
American Academy of Sleep Medicine. International classification of sleep disorders, 2nd edition: Diagnostic and coding manual. Westchester: American Academy of Sleep Medicine; 2006.
Nevsimalova S. Narcolepsy in childhood. Sleep Med Rev. 2009;13:169–80.
Kotagal S, Paruthi S. Narcolepsy in childhood. In: Narcolepsy: a clinical guide. New York, Springer; 2010. p. 55–67.
Lin L, Faraco J, Li R, et al. The sleep disorder, canine narcolepsy, is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell. 1999;98:356–76.
Nishino S, Ripley B, Overeem S, et al. Hypocretin (orexin) deficiency in human narcolepsy. Lancet. 2000;35:39–40.
Saper CB. Staying awake for dinner: hypothalamic integration of sleep, feeding and circadian rhythms. Prog Brain Res. 2006;153:243–52.
Wu MF, John J, Maidment N, Lam HA, Siegel JM. Hypocretin release in normal and narcoleptic dogs after food and sleep deprivation, eating and movement. Am J Physiol Regul Integr Comp Physiol. 2002;283:R1079–86.
Heier MS, Jansson TS, Gautvik KM. Cerebrospinal fluid hypocretin 1 deficiency, overweight and metabolic dysregulation in patients with narcolepsy. J Clin Sleep Med. 2011;7:653–8.
Evenson KR, Ballard K, Lee G, Ammerman A. Implementation of a school based state policy to increase physical activity. J Sch Health. 2009;79:231–8.
Wise MS, Arand DL, Auger RR, Brooks SN, Watson NF. Treatment of narcolepsy and other hypersomnias of central origin. Sleep. 2007;30:1712–27.
Morgenthaler TI, Kapur VK, Brown T, Swick TJ, Alessi C, et al. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep. 2007;30:1705–11.Evidence based discussion of pharmacologic treatment measures.
Quinnell TG, Smith IE. Narcolepsy, idiopathic hypersomnolence, and related conditions. Clin Med. 2011;11:282–6.
Frenette E, Kushida CA. Primary hypersomnias of central origin. Semin Neurol. 2009;29:354–67.
Basetti C, Aldrich MS. Idiopathic hypersomnia: a series of 42 patients. Brain. 1997;120:1423.
Arnulf I, Lin L, Gadoth N, et al. Kleine Levin syndrome: a systematic study of 108 patients. Ann Neurol. 2008;63:482–93.
Dauvilliers Y, Mayer G, Lecendreux M, et al. Kleine Levin syndrome. An autoimmune hypothesis based on clinical and genetic analyses. Neurology. 2002;59:1739–45.
Poppe M, Friebel D, Reuner U, et al. The Kleine-Levin syndrome – effects of treatment with lithium. Neuropediatrics. 2003;34:113–9.
Surges R, Walker MC. A case of late onset Kleine Levin syndrome responding to lamotrigine. Sleep Med. 2009;10:394.
Huang YS, Lakkis C, Guilleminault C. Kleine Levin syndrome: current status. Med Clin N Am. 2010;94:557–62.
American Psychiatric Association. Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders. DSMIV-TR. 4th ed. Washington, DC: American Psychiatric Association; 2000.
Smeets EE, Pelc K, Dan B. Rett syndrome. Mol Syndromol. 2012;2(3–5):113–27.
Elsea SH, Girirajan S. Smith-Magenis syndrome. Eur J Hum Genet. 2008;16(4):412–21.
Zollino M, Murdolo M, Marangi G, et al. On the nosology and pathogenesis of Wolff-Hirschhorn syndrome: geneotype-phenotype correlation analysis of 80 patients and literature review. Am J Med Genet C Semin Med Genet. 2008;148C:257–69.
Boudreau EA, Johnson KP, Jackman AR, Blancato J, Huizing M, et al. Review of disrupted sleep patterns in Smith-Magenis syndrome and normal melatonin secretion in a patient with an atypical interstitial 17p11.2 deletion. Am J Med Genet. 2009;149A:1382–91.
Leger D, Stal V, Quera-Salva MA, Guilleminault C, Paillard M. Disorders of wakefulness and sleep in blind patients. Rev Neurol (Paris). 2001;157(11pt. 2):S135–9.
Leger D, Guilleminault C, Santos C, Paillard M. Sleep/wake cycles in the dark: sleep recorded by polysomnography in 26 totally blind subjects compared with controls. Clin Neurophysiol. 2002;113:1607–14.
Mindell JA, Kuhn B, Lewin DS, Meltzer LJ, Sadeh A. Behavioral treatment of bedtime problems and night wakings in children. Sleep. 2006;29:1263–76.
Richdale AL, Schreck KA. Sleep problems in autism spectrum disorders: prevalence, nature, & possible biopsychosocial aetiologies. Sleep Med Rev. 2009;13:403–11.
Stigler KA, Posey DJ, McDougle CJ. Ramelteon for insomnia in two youths with autism spectrum disorder. J Child Adolesc Psychopharmacol. 2006;16:631–6.
Golubchik P, Sever J, Weizman A. Low-dose quetiapine for adolescents with autistic spectrum disorder and aggressive behavior:open-label trial. Clin Neuropharmacol. 2011;34:216–9.
Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: Diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4:101–19.
Picchietti DL, Allen RP, Walters AS, et al. Restless legs syndrome: prevalence and impact in childhood and adolesence–the Peds REST study. Pediatrics. 2007;120:253–66.
Stefansson H, Rye DB, Hicks A, Petursson H, Ingason A, et al. A genetic risk factor for periodic limb movements in sleep. N Engl J Med. 2007;357:639–47.
Walters AS. Is there a subpopulation of children with growing pains who really have Restless Legs Syndrome? A review of the literature. Sleep Med. 2002;3:93–8.
Kotagal S, Silber MH. Childhood-onset restless legs syndrome. Ann Neurol. 2004;56:803–7.
Simakajornboon N, Kheirandish-Gozal L, Gozal D. Diagnosis and management of restless legs syndrome in children. Sleep Med Rev. 2009;13:149–56.
Picchietti DL, Underwood DJ, Farris WA, et al. Further studies on periodic limb movement disorder and restless legs syndrome in children with attention deficit-hyperactivity disorder. Mov Disord. 1999;14:1000–7.
Chervin RD, Archbold KH, Dillon JE, et al. Associations between symptoms of inattention, hyperactivity, restless legs, and periodic leg movements. Sleep. 2002;25:213–18.
Bogan RK, Cramer Borneman MA, Kushida CA, et al. Long-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study. Mayo Clin Proc. 2010;85:512–21.
Hening WA, Allen RP, Earley CJ, Picchietti DL, Silber MH. Restless legs syndrome task force of the Standards of Practice Committee of the American Academy of Sleep Medicine. An update on the dopamnergic treatment of restless legs dyndrome and periodic limb movement disorder. Sleep. 2004;27:560–83.
Kotagal S. Parasomnias in childhood. Sleep Med Rev. 2009;13:157–68.
Bisulli F, Vignatelli F, Provini F, Leta C, et al. Parasomnias and nocturnal frontal lobe epilepsy (NFLE): lights and shadows–controversial points in the differential diagnosis. Sleep Med. 2011;12 Suppl 2:S27–32.
Guilleminault C, Palombini L, Pelayo R, Chervin RD. Sleepwalking and sleep terrors in prepubertal children: what triggers them? Pediatrics. 2003;111:e17–25.
Tobin JD. Treatment of somnambulism with anticipatory awakening. J Pediatr. 1993;122:426–7.
Arnulf I. REM sleep behavior disorder: motor manifestations and pathophysiology. Mov Disord. 2012;27:677–89.
Lloyd R, Tippmann-Piekert M, Slocumb N, Kotagal S. Characteristics of REM sleep behavior disorder in childhood. J Clin Sleep Med. 2012;8:127–31.
Kunz D, Mahlberg R. A two-part, double blind placebo controlled trial of exogenous melatonin in REM sleep behavior disorder. J Sleep Res. 2010;19:591–6.
Iber C, Ancoli-Israel S, Chesson A, Quan SF, for the American Academy of Sleep Medicine. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. 1st ed. Westchester: American Academy of Sleep Medicine; 2007.
Spitzer AR. Evidence-based methylxanthine use in the NICU. Clin Perinatol. 2012;39:137–48.
Spence J, Pasterkamp H, McDonald PJ. Isolated central sleep apnea in type I Chiari malformation: improvement after surgery. Pediatric Pulmunol. 2010;45:1141–4.
Westwood AJ, Vendrame M, Montouris G, Auerbach SH. Pearls and oy-sters: treatment of central sleep apnea with topiramate. Neurology. 2012;78:e97–9.
Gozal D. New concepts in abnormalities of respiratory control in children. Curr Opin Pediatr. 2004;16:305–8.
Gozal D, Harper RM. Novel insights into congenital hypoventilation syndrome. Curr Opin Pulm Med. 1999;5:335–8.
Roshkow JE, Haller JO, Berdon WE, Sane SM. Hirschprung’s disease, Ondine’s curse, and neuroblastoma–manifestations of neurocristopathy. Pediatr Radiol. 1988;19:45–9.
Swaminathan S, Gilsanz V, Atkinson J, Keens TG. Congenital central hypoventilation syndrome associated with multiple ganglioneuromas. Chest. 1989;96:423–4.
Trochet D, O’brien LM, Gozal D, et al. PHOX2B genotype allows for prediction of tumor risk in congenital central hypoventilation syndrome. Am J Hum Genet. 2005;76:421–6.
Weese-Mayer DE, Berry-Kravis EM, Ceccherini I, et al. An official ATS clinical policy statement: congenital central hypoventilation syndrome: genetic basis, diagnosis, and management. Am J Res Crit Care Med. 2010;181:626–44.
Brunetti L, Rana S, Losppalluti ML, et al. Prevalence of obstructive sleep apnea syndrome in a cohort of 1207 children of Southern Italy. Chest. 2001;120:1930–5.
Lumeng JC, Chervin RD. Epidemiology of pediatric obstructive sleep apnea. Proc Am Thorac Soc. 2008;5:242–52.
Chervin RD, Archbold KH, Dillon JE, et al. Associations between symptoms of inattention, hyperactivity, restless legs, and periodic leg movements. Sleep. 2002;25:213–8.
Gozal D. Obstructive sleep apnea in children: implications for the developing central nervous system. Semin Pediatr Neurol. 2008;15:100–6.
Guilleminault C, Pelayo R, Leger D, et al. Recognition of sleep-disordered breathing in children. Pediatrics. 1996;98:871–82.
Brouillette RT, Morielli A, Leimanis A, et al. Nocturnal pulse oximetry as an abbreviated testing modality for pediatric obstructive sleep apnea. Pediatrics. 2000;105:405–12.
Kheirandish-Gozal L, Gozal D. Intranasal budesonide treatment for children with mild obstructive sleep apnea syndrome. Pediatrics. 2008;122:e149–55.
Brietzke SE, Gallagher D. The effectiveness of tonsillectomy and adenoidectomy in treatment of pediatric obstructive sleep apnea/hypopnea syndrome: a meta-analysis. Otolaryngol Head Neck Surg. 2006;134:979–84.
Ambrosio A, Brigger MT. Pediatric supraglottoplasty. Adv Otorhinolaryngol. 2012;73:101–4.
Sawyer AM, Gooneratne NS, Marcus CL, Ofer D, Richards KC, et al. A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions. Sleep Med Rev. 2011;15:343–56.
Marcus CL, Beck SE, Traylor J, Cornaglia MA, Meltzer LJ, DiFeo N, et al. Randomized, double blind trial of 2 different modes of positive pressure airway therapy on adherence and efficacy in children. J Clin Sleep Med. 2012;8:37–42.
Verhulst SL, Van Gaal L, De Backer W, Desager K. The prevalence, anatomical correlates and treatment of sleep-disordered breathing in obese children and adolescents. Sleep Med Rev. 2008;12:339–46.
Villa MP, Bernkopf E, Pagani J, et al. Randomized controlled study of an oral jaw-positioning appliance for the treatment of obstructive sleep apnea in children with malocclusion. Am J Respir Crit Care Med. 2002;165:123–7.
Guilleminault C, Li KK. Maxillomandibular expansion for the treatment of sleep disordered breathing: preliminary result. Laryngoscope. 2004;114:893–6.
Wise MS, Nichols CD, Grigg-Damberger MM, Marcus CL, Witmans MB, Kirk VG, et al. Executive summary of respiratory indications for polysomnography in children: an evidence based review. Sleep. 2011;34:389–98.
Kotagal S, et al. Executive summary of non-respiratory indications for polysomnography in children: an evidence based review. Sleep. 2012 (in press).
Winkelmann J, Lin L, Schormair B, Kornum BR, Faraco J, Plazzi G, et al. Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy. Hum Mol Genet. 2012;21:2205–10.
Disclosure
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kotagal, S. Treatment of Dyssomnias and Parasomnias in Childhood. Curr Treat Options Neurol 14, 630–649 (2012). https://doi.org/10.1007/s11940-012-0199-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11940-012-0199-0